Open Clinical Trials: Specific U.S. Nationwide Studies
- The U.S. Military HIV Research Program (Regularly Updated)
- The Neurologic AIDS Research Consortium (Regularly Updated)
- AIDS Clinical Trial Group Trials Open for Enrollment (Regularly Updated)
- ESPRIT: Interleukin Study (Regularly Updated)
A large-scale, randomized, international study of the effectiveness of IL-2 in HIV-positive people with CD4+ counts over 300.
- Women's Interagency HIV Study (Regularly Updated)
A large, long-running, ongoing investigation of the clinical, laboratory and psychosocial aspects of HIV infection in women.
- Open Clinical Trials (Summer/Fall 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Wisconsin Participates in START Trial (May 17, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Open Clinical Trials (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- HIV-Positive Adults Needed for Vaccine Study (January 8, 2010)
From TheBody.com
- U.S. Study Seeks Volunteers to Test Benefits of Testosterone Gel in Older Men (November 2, 2009)
A study is recruiting men across the U.S. age 65 and older to test whether the testosterone gel AndroGel can help offset health problems such as anemia, heart disease, muscle loss and decreased sex drive.
From Penn Medicine
On TheBodyPRO.com
- Vaginal Microbicides (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Vicriviroc in People With Dual/Mixed-Tropic HIV (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Maraviroc for CD4 Cell Recovery (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Can Raltegravir Further Reduce Viral Load? (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Once-Daily Raltegravir for Treatment-Naive Patients (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Rilpivirine (TMC278) for Treatment-Naive Patients (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- The Setpoint Study (Study A5217) (May/June 2008)
A randomized study comparing immediate treatment vs. treatment as indicated in newly-infected HIV-positive patients.
In Positively Aware, from Test Positive Aware Network
- Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients (April 15, 2008)
Novel nucleoside-sparing regimen designed to avoid risk of toxicity associated with nucleoside class of HIV drugs.
From Schering-Plough
- New Kind of Antiretroviral, KP-1461, Clinical Trial Recruiting; Interview With Stephen Becker, M.D. (October 11, 2007)
In AIDS Treatment News, from AIDS Treatment News
- Tibotec Therapeutics Announces Initiation of the Largest U.S. Clinical Study Examining HIV Treatment in Treatment-Experienced Adult Women (September 28, 2006)
GRACE trial to explore gender-related differences in response to Prezista-based HIV therapy.
From Tibotec Therapeutics
- Multicenter AIDS Cohort Study (MACS) (March 2005)
One of the longest-running, more significant studies of HIV infection in men, MACS is looking to expand its range to include more participants, especially minorities .
|
Advertisement
|
Email
Glossary
